Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy-Reference-Cited by-同舟云学术

Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy

Published:2011-07-22 Issue:8 Volume:22 Page:1543-1550
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Beck Laurence H.,Fervenza Fernando C.,Beck David M.,Bonegio Ramon G.B.,Malik Fahim A.,Erickson Stephen B.,Cosio Fernando G.,Cattran Daniel C.,Salant David J.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference16 articles.

1. Management of Membranous Nephropathy: When and What for Treatment

2. Rituximab Therapy for Membranous Nephropathy: A Systematic Review

3. Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti-CD20 Monoclonal Antibodies

4. Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study

5. Rituximab treatment of idiopathic membranous nephropathy

Cited by 398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy with rituximab and low dose cyclophosphamide and prednisone in membranous nephropathy;Kidney International Reports;2024-09

2. Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy;Kidney International Reports;2024-09

3. Therapeutic targets in membranous nephropathy: plasma cells and complement;Clinical Kidney Journal;2024-08-13

4. Treatment of membranous nephropathy: a novel approach?;Nephrology Dialysis Transplantation;2024-08-10

5. Macrocarpal B blocks the binding between the phospholipase A2 receptor and its antibodies;Bioorganic & Medicinal Chemistry;2024-08